The modern environment is associated with an increasing burden of non-communicable diseases (NCDs). Mounting evidence implicates environmental exposures, experienced early in life (including in utero), in the aetiology of many NCDs, though the cellular/molecular mechanism(s) underlying this elevated risk across the life course remain unclear. Epigenetic variation has emerged as a candidate mediator of such effects. The Barwon Infant Study (BIS) is a population-derived birth cohort study (n ¼ 1074 infants) with antenatal recruitment, conducted in the south-east of Australia (Victoria). BIS has been designed to facilitate a detailed mechanistic investigation of development within an epidemiological framework. The broad objectives are to investigate the role of specific environmental factors, gut microbiota and epigenetic variation in early-life development, and subsequent immune, allergic, cardiovascular, respiratory and neurodevelopmental outcomes. Participants have been reviewed at birth and at 1, 6, 9 and 12 months, with 2-and 4-year reviews under way. Biological samples and measures include: maternal blood, faeces and urine during pregnancy; infant urine, faeces and blood at regular intervals during the first 4 years; lung function at 1 month and 4 years; cardiovascular assessment at 1 month and 4 years; skin-prick allergy testing and food challenge at 1 year; and neurodevelopmental assessment at 9 months, 2 and 4 years. Data access enquiries can be made at [www.barwoninfantstudy.org.au] or via [peter.vuillermin@deakin.edu.au].
Why was the study set up?
To reduce the burden of NCDs in the modern environment, we need a detailed understanding of the mechanisms by which specific early-life environmental exposures predispose to subsequent health outcomes. In the current era of 'omics' technology, 1 the Barwon Infant Study (BIS) has been designed to facilitate laboratory investigation of development and disease in the context of a population-derived antenatally recruited cohort with detailed environmental data and extensive, longitudinally assembled biological specimens. BIS involves an overarching investigation of potential mediators of environmental risk such as the human epigenome (BIS Epigenome) and microbiome (BIS Microbiome). With respect to disease-related phenotype measurement, the aims are characterized with reference to biological systems: BIS Immune, BIS Respiratory, BIS Cardiovascular and BIS Neurodevelopment.
BIS Epigenome
The objective of BIS Epigenome is to investigate the interplay between genetic, environmental and epigenetic factors, both to define the level of variation in the early-life epigenome in response to specific exposures, and also to identify epigenetic variation associated with healthy development and disease. Considerable evidence exists in support of the Developmental Origins of Health and Disease (DOHaD) hypothesis that implicates early-life environmental exposures as altering non-communicable disease (NCD) risk; and epigenetic variation has emerged as candidate mediator of such long-term 'programming' effects. [2] [3] [4] [5] [6] However, establishing a role for early-life epigenetic variability as a mediator of NCDs is challenging, particularly as epigenetic marks are subject to genetic, temporal and spatial (tissue-specific) variability. As such, the importance of epigenetics cannot be reliably inferred retrospectively, nor from non-target tissue. 7 In this context, BIS Epigenome has been designed to address a wide range of hypotheses along a proposed causal pathway (Figure 1 ), by maximizing exposure-related data, diversity of collected biospecimens, and phenotypic data (including clinical parameters) at multiple time points commencing prior to birth. Our initial aim is to test the hypothesis that a subset of methylation-sensitive genes (MSGs), regulating naïve
Key Messages
• BIS has been designed to investigate during early life: (i) the relationship between the maternal and infant gut microbiome, epigenetic profile and immune development; (ii) the determinants of lung development and function; (iii) the initiation and potentiation of atherosclerosis and cardiovascular disease risk; and (iv) factors contributing to neurodevelopmental outcomes.
• A series of nested case-cohort studies is being conducted in order to address research questions relating to biological mechanisms.
• Integrated cohort-wide genomic and epigenomic analysis will investigate molecular mediators of risk for a wide range of NCDs.
• Maternal folate levels during pregnancy may influence the epigenetic profile of the developing infant and were higher in BIS than reported in previous population-derived pregnancy cohorts. Th-cell function, determines susceptibility to allergic disease. This results in altered gene expression, differential capacity to generate Th-cell subtypes, and altered immune responses following cell activation.
BIS Microbiome
The objective of BIS Microbiome is to conduct a longitudinal investigation of the relationship between the composition and metabolic products of the maternal and infant gut microbiome, immune development (including epigenetic profiles) and allergic disease, asthma and atherosclerosis. Recent evidence in animal models has shown that dietary factors may modify the risk of allergic disease and asthma via changes in the large bowel microbiome and the production of short chain fatty acids (SCFAs), which in turn have clearly delineated effects on the local and systemic immune system. 8, 9 It has also been shown that
Clostridia regulate innate lymphoid cell function and intestinal permeability to protect against allergen sensitization. 10 These findings may be of substantial public health significance, but human studies are now required. Our initial aims are to test the hypotheses that a faecal profile at 1 month of postnatal age characterized by (i) low diversity, (ii) low Clostridia and (iii) low SCFAs is associated with an increased risk of IgE-mediated food allergy at age 1 year.
BIS Immune
The objective of BIS Immune is to evaluate the relationship between pre-and postnatal microbial exposure, the large bowel microbiome and its metabolites, vitamin D status (VDS), early-life immune development and risk of allergic disease, asthma and other NCDs. Recent studies have suggested that increased regulatory T (Treg) cells may contribute to reduced risk of allergic disease and asthma among children from farming environments. 11 There is also emerging evidence that low VDS may be associated with an increased risk of allergic outcomes and that this relationship may be modified by genetic and or environmental factors.
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Our initial aims are to test the hypotheses: that a reduced proportion of Treg cells in peripheral blood during early infancy is associated with an increased risk of food allergy; that the deficit in Treg relates to the composition and metabolic products of the large bowel microbiome; and that the relationship between VDS and food allergy is modified by the composition of the large bowel microbiome.
BIS Respiratory
The objective of BIS Respiratory is to investigate the relationship between postnatal immune development, lower respiratory tract illness, aeroallergen sensitization and deterioration in lung function during the first 3 years of life. [13] [14] [15] Early-life respiratory development can have a substantial impact on long-term respiratory health. 16 Early-life immune dysregulation is associated with an increased risk of both aeroallergen sensitization and febrile lower respiratory tract infections during the first years of life. 13 In turn, aeroallergen sensitization and febrile lower respiratory tract infections during early life are associated with an increased risk of asthma in later childhood. 14 Both processes result in respiratory inflammation during a critical period of lung development. 15 
BIS Cardiovascular
The objective of BIS Cardiovascular is to conduct a comprehensive longitudinal investigation of factors contributing to the development of the inflammatory process of atherosclerosis and of other cardiovascular disease (CVD) risk factors, from early life onwards. Current preventive strategies for CVD target adults, but the underlying pathology of CVDatherosclerosis-often begins in utero 17 and progresses for decades before becoming clinically apparent. 18 Early life is therefore a critical period for the initiation and progression of atherosclerosis but is a largely overlooked window of opportunity for prevention. This is the first study to investigate aortic intima-media thickness (IMT) longitudinally from birth into early childhood and its relationship with other cardiovascular phenotypes. Our initial aim is test the hypotheses that perinatal inflammation is associated with increased aortic intima-media thickness at 1 month of age, and that early-life infection burden is associated with an adverse cardiovascular risk in pre-school children.
BIS Neurodevelopment
The objective of BIS Neurodevelopment is to investigate whether higher levels of exposure to specific modern chemicals are associated with deficits in validated measures of executive function, memory, behaviour, language and general cognitive development during the first years of life. There has been a well-documented increase in the burden of disorders of development and behaviour within paediatrics. 19 The environmental factors contributing to this increase are unknown, but there is considerable concern regarding the role of modern environmental chemical exposures. 20 The array of biospecimens collected in BIS provides a unique opportunity to assess the association between exposure to specific modern chemical exposures in early life and adverse neurodevelopment. The potential neurotoxicants currently under investigation include bisphenol A (BPA) and phthalates. The relationship between these exposures and immune development will also be explored.
Who is in the sample?
The Barwon region, which includes and surrounds the city of Geelong, has a range of primary industries and incorporates metropolitan, rural and coastal areas. The population characteristics are similar to those of the Australian population overall, with the exception that there is a smaller proportion of families from non-English-speaking backgrounds. Approximately 260 000 people live in the Barwon region and there are about 3000 live births per year. More than 90% of these occur at either Geelong Hospital (a government-funded healthcare facility) or St John of God Hospital (a private facility). At both hospitals pregnant women have an antenatal book-in appointment at approximately 15 weeks of pregnancy, and women attending this antenatal clinic were invited to participate in BIS. The eligibility criteria are shown in Table 1 . The 3-year recruitment phase was completed in June 2013 (n ¼ 1158 women). The baseline characteristics of the participating infants (n ¼ 1074) are shown in Table 2 . From monitoring the attendance of over 1000 women at the 15-week hospital book-in appointments, more than 90% of attendees reported meeting the self-assessed eligibility criteria, and among those invited to participate, our recruitment rate was approximately 33%. Focus group work indicates that this relates to the high participant burden and the bio-intensive nature of the protocol. A comparison of participating mothers and non-responders is shown in Table 3 . For certain analyses we will examine potential sensitivity of results to participation bias by weighting observed data by the inverse of the estimated probability of participation, 21 with these estimates obtained as predicted values from a logistic regression of participation on sex, maternal age, household size and socioeconomic status by postcode.
How often are cohort members being followed-up?
There have been frequent, and ongoing, participant contacts during pregnancy and the first postnatal years ( Table 4 ). The 4-year reviews commenced in late 2014 and the follow-up schedule beyond 4 years are yet to be finalized. The retention rate for the 1-year reviewwas 894 of 1074 eligible infants (83.2%) ( Figure 2 ). Participants who had not completed the 1-year review were more likely to have been born in the government-funded hospital and to have a lower birthweight; their parents were more likely to be younger and to have a lower income; and their mothers were less likely to have attended tertiary education and were more likely to have smoked cigarettes or been exposed to passive smoke during pregnancy (Table 5) .
What has been measured?
Wherever possible we have used questionnaire items for which validity has been examined and established. Questionnaires have been developed to facilitate pooling of data with other birth cohort studies being conducted in Australia (such as the HealthNuts study in Melbourne   22 ) and internationally. In particular, BIS is a member the International Childhood Cancer Cohort Consortium (I4C) 23 and the International Inflammation Network (in-FLAME). The questionnaire domains and timing are shown in Table 4 . The schedule of biosample collection and funded assays during pregnancy and the first 3 years of life is shown in Table 6 . The schedule of physical, physiological and clinical measurements is shown in Table 7 . 
Assessment of eczema status
The presence of eczema is defined using the Williams UK diagnostic criteria. 24 The severity of eczema is assessed using the SCORAD. 25 Atopic eczema is defined as the presence of eczema plus allergic sensitization (as demonstrated by a positive skin-prick test to one or more allergens).
Assessment of allergic sensitisation
Skin-prick allergy testing (SPT) is performed according to standard guidelines. 26 A positive skin-prick test is defined as a wheal diameter at least 2 mm greater than that produced by a negative control solution, measured at 15 min. We perform SPT using Quintips V R to the following allergens: cow's milk, egg, peanut, sesame, cashew, dust mite (Dermatophagoides pteronyssinus 1), cat, dog, rye grass and Alternaria tenius (Hollister Stier, Aloystal, ALK V R ).
Assessment of IgE-mediated food allergy
Infants who exhibit a positive SPT to any of the five foods tested are invited to attend a BIS food allergy clinic for clinical assessment and/or oral food challenge. Infants with a clear history of an immediate-type reaction following exposure to a specific food to which they are skin-prick positive are classified as allergic to that food. In the absence of such history, oral food challenges for egg, peanut, sesame and cashew are undertaken regardless of the SPT wheal size, 22 using standardized food challenge protocols. 27 A positive food challenge is defined according to the protocol established by the HealthNuts study.
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Assessment of lung function Multiple Breath Washout (MBW) is a recently validated technique for measuring lung function, which is available for use in infants during natural (unsedated) sleep. 29 The technique measures the degree of ventilation inhomogeneity (inefficient breathing), which has emerged as an important feature of early respiratory disease processes. 30 In individuals with asthma, ventilation inhomogeneity reflects the degree of peripheral airway obstruction and is a major determinant of airway responsiveness. 32 
Assessment of cardiovascular risk in early life
The distal aorta is the optimal site to assess early markers of atherosclerosis in infancy. 33 Aortic IMT is a validated measure of preclinical atherosclerosis in childhood, but one that has only recently been applied to newborns. 34 The extent of atherosclerosis in the aorta correlates with the extent of atherosclerosis in the coronary arteries in later life (r ¼ 0.37, p ¼ 0.001). 35 In both unselected children and in those at increased risk of NCDs (e.g. diabetes or hypercholesterolaemia), aortic IMT is actually a more sensitive measure of atherosclerosis than carotid IMT. [36] [37] [38] We will 
also measure blood pressure at all ages and, additionally, carotid IMT and pulse wave velocity (a validated measure of arterial elasticity) at 3 years of age.
Assessment of neurodevelopment
At 9 months we conduct direct measurements of executive function and processing speed, 39, 40 in combination with parent-reported measures of global development 41 and temperament. 42 At 18 months early language development is assessed by questionnaire. 43 At 2 years we conduct a direct measurement of cognitive, language and motor development using the Bayley Scales of Infant and Toddler Development (third edition), 44 in combination with the Child Behaviour Checklist. 45 Executive function is again assessed at 4 years.
What has it found? Key findings and publications
We have published review and or hypothesis papers regarding a number of the investigations in BIS, [46] [47] [48] described the potential role of cord blood flow cytometry as a population screening strategy 49 and reported the performance of baseline measurement techniques. 50 Recruitment and definition of the BIS inception cohort was completed in December 2013 and numerous manuscripts are in preparation. the risk of neural tube defects (NTDs) and other major congenital malformations. 51 In this context, folic acid food fortification programmes have been introduced in many parts of the world-including Australia in 2009. Women are also advised to increase folate intake during pregnancy. 52 Of potential concern, folic acid in pregnancy has been linked to epigenetic changes associated with an increased risk of allergic disease and asthma, 53 although the evidence from human cohort studies is conflicting. 54 The implementation of mandatory fortification of flour with folic acid has been associated with a reduced prevalence of folate deficiency among Australian women of childbearing age, 55 Figure 3 ). These levels are higher than have been reported in previous population-derived cohorts of pregnant women.
Maternal folate levels during pregnancy
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What are the main strengths and weaknesses?
The major strengths of BIS are the population-derived antenatal sampling frame, in combination with a highly detailed array of longitudinally assembled biospecimens and physiological/clinical measures. The majority of previous and contemporary birth cohort studies are: either (i) substantially larger than BIS but have a much less extensive schedule of biospecimen collection and physiological measures (depth of phenotyping); or (ii) involve a similar level of participant burden to BIS, but are undertaken among smaller cohorts focused on particular phenotypic outcomes. The population-derived design of BIS will enable us to address a range of outcomes, and facilitates a nested case-cohort approach to research questions where the biospecimen processing and analysis are resource-intensive; for example, studies involving isolation and detailed characterization of specific cryopreserved mononuclear cell populations. A nested case-cohort approach can provide a similar level of rigour and statistical power to using the entire cohort for addressing resource-intensive research questions, but is far more efficient in terms of both cost and biosamples. The detailed protocol poses high participant burden, so optimizing participation and attrition rates among the unselected cohort is an important challenge. The Barwon setting is well suited to this approach, as it is serviced by a single obstetric and paediatric network and enjoys a strong sense of community, while also encompassing a substantial population.
The research agenda has evolved to incorporate a number of different health outcomes that have origins in early life and which are believed/hypothesized to share many environmental and immunological determinants. It has been designed to foster interdisciplinary synergies and cross-pollination between different lines of investigation. For example, the detailed description of gut microbiota and immune development in the BIS Immune component are likely to be relevant to the initiation and potentiation of the inflammatory process under investigation in BIS Respiratory and BIS Cardiovascular, respectively.
There are limitations to the study. By international standards, a sample of 1074 infants is a relatively small cohort, and this will limit our capacity to investigate uncommon outcomes and to perform exploratory genomic association studies, especially for dichotomous phenotypes. We have judged that, in view of the high participant burden, it would be difficult to maintain an adequate retention rate among a larger, multi-centre cohort. Our participation fraction was approximately 33%, which may detract from the population representativeness of the cohort but is unlikely to introduce substantial bias in estimates of exposure-disease associations. 57 These limitations are, however, offset by the detailed longitudinal data and biological specimens, as well as physiological and clinical measurements. The capacity of epidemiological studies, including cohorts, to incorporate molecular biology and 'omics' has recently been discussed in depth. 1 With this in mind, BIS has been designed to achieve a balance between statistical power, deep phenotyping and a manageable level of participant burden.
Can I get hold of the data? Where can I find out more? 
